CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182908. A total of 6 filers reported holding CRISPR THERAPEUTICS AG in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,052,891 | +28.4% | 149,100 | +62.1% | 0.01% | +25.0% |
| Q1 2024 | $6,270,720 | -47.3% | 92,000 | -51.6% | 0.00% | -50.0% |
| Q4 2023 | $11,900,260 | +66.6% | 190,100 | +20.8% | 0.01% | +33.3% |
| Q3 2023 | $7,144,386 | -24.1% | 157,400 | -6.1% | 0.01% | -33.3% |
| Q2 2023 | $9,409,064 | +11.4% | 167,600 | -10.3% | 0.01% | -10.0% |
| Q1 2023 | $8,448,964 | +24.9% | 186,800 | +12.3% | 0.01% | -9.1% |
| Q4 2022 | $6,764,160 | -42.7% | 166,400 | -7.9% | 0.01% | -26.7% |
| Q3 2022 | $11,809,000 | -7.2% | 180,700 | -13.7% | 0.02% | -16.7% |
| Q2 2022 | $12,731,000 | +65.8% | 209,500 | +71.3% | 0.02% | +125.0% |
| Q1 2022 | $7,677,000 | -5.1% | 122,300 | +14.6% | 0.01% | +14.3% |
| Q4 2021 | $8,086,000 | -49.7% | 106,700 | +7.5% | 0.01% | -65.0% |
| Q2 2021 | $16,076,000 | +34.6% | 99,300 | +1.3% | 0.02% | +17.6% |
| Q1 2021 | $11,941,000 | – | 98,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMC-Chicago, LLC | 186,800 | $8,448,964 | 0.01% |
| GROUP ONE TRADING, L.P. | 60,800 | $2,749,984 | 0.01% |
| JANE STREET GROUP, LLC | 231,400 | $10,466,222 | 0.00% |
| SIMPLEX TRADING, LLC | 89,200 | $4,034 | 0.00% |
| OSAIC HOLDINGS, INC. | 1 | $1,450 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |